| Charles Ira Woods Iii, MD | |
|
750 E Adams St, Syracuse, NY 13210-2306 | |
| (315) 464-4633 | |
| Not Available |
| Full Name | Charles Ira Woods Iii |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 41 Years |
| Location | 750 E Adams St, Syracuse, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588691760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 179645 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospital S U N Y Health Science Center | Syracuse, NY | Hospital |
| Crouse Hospital | Syracuse, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Otolaryngology Associates Of Central New York, Llp | 0941109789 | 16 |
News Archive
Researchers at the University of Pittsburgh Cancer Institute (UPCI) have identified the oncoprotein that allows a common and usually harmless virus to transform healthy cells into a rare but deadly skin cancer called Merkel Cell Carcinoma.
The White House formally announced the drug manufacturers' plan to lower Medicare drug prices Monday. While details still remain unclear, it appears drug companies may benefit from the deal.
Cancer information charity CancerBACUP is calling for action following today's Healthcare Commission report, which highlights particular concerns about patient information and the lack of patient involvement in their treatment and care.
GlaxoSmithKline, Philadelphia, PA, USA (GSK) and Merck & Co., Inc., Whitehouse Station, NJ, USA (Merck), announced today that they have entered into an agreement for over-the-counter (OTC) marketing rights for MEVACOR (lovastatin).
› Verified 6 days ago
| Entity Name | University Otolaryngology Associates Of Central New York, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497796361 PECOS PAC ID: 0941109789 Enrollment ID: O20031231000293 |
News Archive
Researchers at the University of Pittsburgh Cancer Institute (UPCI) have identified the oncoprotein that allows a common and usually harmless virus to transform healthy cells into a rare but deadly skin cancer called Merkel Cell Carcinoma.
The White House formally announced the drug manufacturers' plan to lower Medicare drug prices Monday. While details still remain unclear, it appears drug companies may benefit from the deal.
Cancer information charity CancerBACUP is calling for action following today's Healthcare Commission report, which highlights particular concerns about patient information and the lack of patient involvement in their treatment and care.
GlaxoSmithKline, Philadelphia, PA, USA (GSK) and Merck & Co., Inc., Whitehouse Station, NJ, USA (Merck), announced today that they have entered into an agreement for over-the-counter (OTC) marketing rights for MEVACOR (lovastatin).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Ira Woods Iii, MD 750 E Adams St, Syracuse, NY 13210-2306 Ph: (315) 464-4633 | Charles Ira Woods Iii, MD 750 E Adams St, Syracuse, NY 13210-2306 Ph: (315) 464-4633 |
News Archive
Researchers at the University of Pittsburgh Cancer Institute (UPCI) have identified the oncoprotein that allows a common and usually harmless virus to transform healthy cells into a rare but deadly skin cancer called Merkel Cell Carcinoma.
The White House formally announced the drug manufacturers' plan to lower Medicare drug prices Monday. While details still remain unclear, it appears drug companies may benefit from the deal.
Cancer information charity CancerBACUP is calling for action following today's Healthcare Commission report, which highlights particular concerns about patient information and the lack of patient involvement in their treatment and care.
GlaxoSmithKline, Philadelphia, PA, USA (GSK) and Merck & Co., Inc., Whitehouse Station, NJ, USA (Merck), announced today that they have entered into an agreement for over-the-counter (OTC) marketing rights for MEVACOR (lovastatin).
› Verified 6 days ago
Dr. William Michael Harmand, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4633 | |
Dr. Alexandra Elizabeth Quimby, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-7281 Fax: 315-464-7298 | |
Anthony Joseph Mortelliti, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4633 | |
Erinn White, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3906 E Genesee St, Syracuse, NY 13214 Phone: 315-251-1093 Fax: 315-251-1571 | |
Dr. Ryan Winters, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 750 E Adams St, Suny Upstate Dpt Of Otolaryngology, Syracuse, NY 13210 Phone: 315-464-4636 | |
Adetokunbo Obayemi Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 East Adams Street, Cwb Rm 251, Syracuse, NY 13210 Phone: 201-431-5751 | |
Haidy Adly Marzouk, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Dept. Of Otolaryngology, Syracuse, NY 13210 Phone: 315-464-5540 |